Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 2 hours ago
Clinical Trials Information System (CTIS) bitesize talk: Annual safety report (ASR) new safety module, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 23 July 2026, 13:00 (CEST) to 23 July 2026, 14:30 (CEST)
about 2 hours ago
Clinical Trials Information System (CTIS) bitesize talk: Annual safety report (ASR) new...
HMPC meeting report on European Union herbal monographs, guidelines and other activities - 6-8 July 2026
about 2 hours ago
HMPC meeting report on European Union herbal monographs, guidelines and other activities...
Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance, qualification of biomarkers and parallel HTACG/EMA Joint Scientific Consultation requests
about 2 hours ago
Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance...
Template - Request for accelerated assessment pursuant to Article 14(9) of Regulation (EC) No 726/2004' to be replaced by 'Briefing Note and Recommendations on a Request for Accelerated Assessment Pursuant to Article 14 (9) of Regulation (EC) No 726/2004
about 3 hours ago
Template - Request for accelerated assessment pursuant to Article 14(9) of Regulation...
Template - Request for accelerated assessment pursuant to Article 14(9) of Regulation (EC) No 726/2004' to be replaced by 'Briefing Note and Recommendations on a Request for Accelerated Assessment Pursuant to Article 14 (9) of Regulation (EC) No 726/2004
about 3 hours ago
Template - Request for accelerated assessment pursuant to Article 14(9) of Regulation...
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 16, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation...
Concept paper on the development of a reflection paper on the non-clinical requirements for severely debilitating or life-threatening diseases
about 5 hours ago
Concept paper on the development of a reflection paper on the non-clinical...
Non-clinical requirements for severely debilitating or life-threatening diseases
about 5 hours ago
Non-clinical requirements for severely debilitating or life-threatening diseases
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation: 17/03/2011, Revision: 42, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation...
Human medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date...